9-ING-41
Showing 1 - 25 of >10,000
Pancreatic Adenocarcinoma Trial in Fairway (9-ING-41, Retifanlimab, Gemcitabine)
Active, not recruiting
- Pancreatic Adenocarcinoma
- 9-ING-41
- +3 more
-
Fairway, KansasKansas University Cancer center
Nov 2, 2022
Refractory Cancer, Refractory Tumor, Cancer Pediatric Trial in United States (9-ING-41, Irinotecan, Temozolomide)
Recruiting
- Refractory Cancer
- +10 more
- 9-ING-41
- +4 more
-
Aurora, Colorado
- +7 more
Dec 31, 2022
Pancreatic Adenocarcinoma, Pancreatic Adenocarcinoma Metastatic Trial in Boston (FOLFIRNINOX, Losartan, 9-ING-41)
Recruiting
- Pancreatic Adenocarcinoma
- Pancreatic Adenocarcinoma Metastatic
- FOLFIRNINOX
- +2 more
-
Boston, MassachusettsMassachusetts General Hospital Cancer Center
Jun 7, 2022
Salivary Gland Carcinoma, Adenoid Cystic Carcinoma, Salivary Gland Cancer Trial in Boston (9-ING-41, Carboplatin)
Withdrawn
- Salivary Gland Carcinoma
- +3 more
- 9-ING-41
- Carboplatin
-
Boston, MassachusettsDana-Farber Cancer Institute
Feb 5, 2022
Salivary Gland Cancer, Recurrent Salivary Gland Cancer, Metastatic Cancer Trial in Boston (9-ING-41, Carboplatin)
Recruiting
- Salivary Gland Cancer
- +3 more
- 9-ING-41
- Carboplatin
-
Boston, Massachusetts
- +1 more
Oct 15, 2021
Soft Tissue Sarcoma, Undifferentiated Pleomorphic Sarcoma, Myxofibrosarcoma Trial in Providence (Gemcitabine, 9-ING-41,
Withdrawn
- Soft Tissue Sarcoma
- +12 more
- Gemcitabine
- +2 more
-
Providence, Rhode Island
- +1 more
Nov 30, 2021
Acute Myeloid Leukemia, Myelodysplastic Syndrome Trial in Houston (procedure, drug, other)
Active, not recruiting
- Acute Myeloid Leukemia
- Myelodysplastic Syndrome
- Allogeneic Hematopoietic Stem Cell Transplantation
- +7 more
-
Houston, TexasM D Anderson Cancer Center
Oct 6, 2022
Primary Myelofibrosis, Secondary Myelofibrosis Trial in Seattle (procedure, drug, other, radiation)
Active, not recruiting
- Primary Myelofibrosis
- Secondary Myelofibrosis
- Allogeneic Hematopoietic Stem Cell Transplantation
- +11 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Jan 10, 2023
SGA, Turner Syndrome, Noonan Syndrome, ISS Trial in Worldwide (Somapacitan)
Not yet recruiting
- SGA, Turner Syndrome, Noonan Syndrome, ISS
-
Sacramento, California
- +14 more
Jan 29, 2023
Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Erythroid Leukemia, Acute Megakaryoblastic Leukemia
Completed
- Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
- +14 more
- Aldesleukin
- +7 more
-
Houston, TexasM D Anderson Cancer Center
Jul 31, 2022
Pharmacogenetic Testing of Unwanted Adverse Drug Reactions or
Recruiting
- Adverse Drug Reaction
- Therapy Failure
- Buccal swab
- +4 more
-
Basel, SwitzerlandDepartment of Pharmaceutical Sciences, University Basel
Nov 24, 2021
Brodalumab in Plaque Psoriasis to Understand Impact on Quality
Recruiting
- Psoriasis
- Brodalumab
- Matched cohort
-
Calgary, Alberta, Canada
- +33 more
Oct 8, 2022
Acute Leukemia, Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Chronic Myelogenous Leukemia, BCR-ABL1 Positive Trial
Active, not recruiting
- Acute Leukemia
- +14 more
- Busulfan
- +10 more
-
Duarte, CaliforniaCity of Hope Medical Center
Nov 18, 2022
Acute Lymphoblastic Leukemia in Remission, Acute Myeloid Leukemia in Remission, Allogeneic Hematopoietic Stem Cell
Completed
- Acute Lymphoblastic Leukemia in Remission
- +6 more
- Allogeneic Bone Marrow Transplantation
- +8 more
-
Houston, TexasM D Anderson Cancer Center
Dec 15, 2021
Hepatitis B, Chronic Trial in Worldwide (JNJ-73763989, JNJ-64300535, ETV monohydrate)
Active, not recruiting
- Hepatitis B, Chronic
- JNJ-73763989
- +4 more
-
Edegem, Belgium
- +12 more
Jan 17, 2023
Chronic Hand Eczema Trial in Canada, Spain, United Kingdom (Delgocitinib, Cream vehicle)
Recruiting
- Chronic Hand Eczema
- Delgocitinib
- Cream vehicle
-
Darlinghurst, Australia
- +25 more
Dec 12, 2022
Hematopoietic and Lymphoid Cell Tumor, High Risk Acute Myeloid Leukemia, High Risk Myelodysplastic Syndrome Trial in Houston
Active, not recruiting
- Hematopoietic and Lymphoid Cell Neoplasm
- +13 more
- Allogeneic Hematopoietic Stem Cell Transplantation
- +9 more
-
Houston, TexasM D Anderson Cancer Center
Feb 8, 2022
Atherosclerotic Cardiovascular Disease, Atherosclerotic Cardiovascular Disease Risk Equivelents, Elevated Low Density
Active, not recruiting
- Atherosclerotic Cardiovascular Disease
- +2 more
- Inclisiran
- Behavioural Support
-
Sale, Cheshire, United Kingdom
- +16 more
Jan 20, 2023
Acute Myeloid Leukemia, Adult Acute Megakaryoblastic Leukemia, Adult Acute Monoblastic Leukemia Trial in United States
Completed
- Acute Myeloid Leukemia
- +19 more
- Allogeneic Hematopoietic Stem Cell Transplantation
- +8 more
-
Lewes, Delaware
- +16 more
Aug 3, 2022
Spasticity With Multiple Sclerosis Trial in Worldwide (Nabiximols, Placebo)
Recruiting
- Spasticity With Multiple Sclerosis
- Nabiximols
- Placebo
-
Denver, Colorado
- +29 more
Jun 30, 2022
Disorder of Consciousness, Paralysis, Motor Neuron Disease Trial in Ireland, United Kingdom (Motor imagery based EEG-BCI)
Recruiting
- Disorder of Consciousness
- +4 more
- Motor imagery based EEG-BCI
-
Dublin, Ireland
- +19 more
Sep 20, 2022
Hepatitis B, Chronic Trial in Worldwide (IMC-I109V-101 Single Ascending Dose, IMC-I109V-101 Multiple Ascending Doses)
Recruiting
- Hepatitis B, Chronic
- IMC-I109V-101 Single Ascending Dose
- IMC-I109V-101 Multiple Ascending Doses
-
Los Angeles, California
- +19 more
May 10, 2023